Please ensure Javascript is enabled for purposes of website accessibility Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy

Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy

Content Details
Pharmacovigilance and drug information Department News and Safety Alerts
Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy
14/05/2026

Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy

View Download
0
Cir.No. 53 of 2026 - Regarding Update to Health Care Professionals About Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphy
Was this page helpful?
0 visitors liked this page of total 0 visitors
Be the first to evaluate this page

Add Reason (choose at least one)

الرجاء اختيار سببان كحد أعلى

هذا الحقل مطلوب

الرجاء كتابة نص صحيح

الملاحظات يجب ان تكون اقل من ٢٥٠ حرف

Share this page
//
Last updated: 2 days ago (2026/05/16)
Follow Us On